focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYEW.L Regulatory News (YEW)

  • There is currently no data for YEW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - YEW ID

5 Jan 2022 15:30

RNS Number : 5496X
Syquant Capital
05 January 2022
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Syquant Capital

Company dealt in

Yew Grove REIT plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

EUR 0.01 ordinary shares

Date of dealing

January 04, 2022

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

1,838,755 (1.47%)

(3) Options and agreements to purchase/sell

Total

1,838,755 (1.47%)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

Total

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

 

Increased long

20,000

1,004 EUR

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

January 5th, 2022

Contact name

Alexandre Chevtchenko

Telephone number

+33 1 42 56 92 93

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEBKPBQQBKDQDK
Date   Source Headline
30th Jun 20207:00 amRNSLTIP Option Awards / PDMR Notification
29th Jun 202012:24 pmRNSSecond Quarter Dividend
18th Jun 20204:49 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSRent Collection Update
29th May 20201:09 pmRNSResult of EGM
29th May 20201:02 pmRNSResult of AGM
19th May 202010:18 amRNSUpdate on upcoming General Meetings
28th Apr 202011:27 amRNSAnnual Report and Notice of AGM and EGM
24th Apr 20207:00 amRNSPublication of Annual Report
15th Apr 20207:00 amRNSTrading and Covid-19 Update & Dividend Declaration
6th Apr 20205:00 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSPreliminary Results
3rd Mar 20204:27 pmRNSFacility Increase
13th Feb 202012:06 pmRNSFourth Quarter Dividend
7th Feb 20207:00 amRNSCompletion of Acquisition
31st Jan 20207:00 amRNSFacility Increase
23rd Jan 20202:00 pmRNSChange of Adviser
23rd Jan 20208:38 amRNSDirector Declaration
16th Jan 20203:51 pmRNSHolding(s) in Company
9th Jan 20205:57 pmRNSHolding(s) in Company
20th Dec 20196:08 pmRNSCompletion of acquisition of office building
19th Dec 20192:55 pmRNSAcquisition of portfolio of six office properties
10th Dec 201910:59 amRNSDirector/PDMR Shareholding
10th Dec 201910:58 amRNSDirector/PDMR Shareholding
10th Dec 201910:57 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:54 amRNSDirector/PDMR Shareholding
9th Dec 20192:02 pmRNSHolding(s) in Company
6th Dec 20193:20 pmRNSHolding(s) in Company
6th Dec 20198:00 amRNSEuronext Growth Dublin Notice
4th Dec 20193:42 pmRNSResult of Placing
22nd Nov 20197:00 amRNSProposed Placing
11th Nov 20197:00 amRNSSale of non-core property
1st Nov 20197:00 amRNSIDA Ireland Building Acquisition
26th Sep 20194:39 pmRNSThird Quarter Dividend
4th Sep 20191:50 pmRNSInterim Results
19th Jul 20193:30 pmRNSAcquisition of Portfolio
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:36 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
12th Jul 20198:00 amRNSEuronext Growth Dublin Notice
11th Jul 20195:07 pmRNSRevolving Loan Facility Increase
11th Jul 201912:20 pmRNSResult of EGM and Total Voting Rights
26th Jun 20193:05 pmRNSSecond Quarter Interim Dividend Confirmation
18th Jun 201912:00 pmRNSResult of Placing and Notice of EGM
13th Jun 20197:00 amRNSAnnouncement of Share Issuance Programme
29th May 20193:27 pmRNSLease surrender

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.